Folate quenches oxidative damage in brains of apolipoprotein E-deficient mice: Augmentation by vitamin E

Molecular Brain Research

Volumn 108, Issue 1-2, 2002, Pages 1-6

  Shea, Thomas B ^a   Rogers, Eugene ^a  

^a University of Massachusetts Lowell   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E4; BUFFER; FOLIC ACID; IRON; RETINOL; THIOBARBITURIC ACID REACTIVE SUBSTANCE; ALPHA TOCOPHEROL; ANTIOXIDANT; EDIBLE OIL; HOMOCYSTEINE;

ALLELE; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CONTROLLED STUDY; DIET SUPPLEMENTATION; GENETIC DAMAGE; HYPERLIPOPROTEINEMIA TYPE 3; IRON INTAKE; KNOCKOUT MOUSE; MOUSE; NERVE DEGENERATION; NONHUMAN; NUTRITIONAL DEFICIENCY; OXIDATIVE STRESS; PRIORITY JOURNAL; VITAMIN INTAKE; ANIMAL; BLOOD; BRAIN; C57BL MOUSE; GENETICS; LIVER; METABOLISM; MOUSE MUTANT; OXIDATION REDUCTION REACTION;

ANIMALS; ANTIOXIDANTS; APOLIPOPROTEINS E; BRAIN; DIETARY FATS, UNSATURATED; FOLIC ACID; HOMOCYSTEINE; IRON, DIETARY; LIVER; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OXIDATION-REDUCTION; THIOBARBITURIC ACID REACTIVE SUBSTANCES; VITAMIN E;

EID: 0037121817     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(02)00412-6     Document Type: Article

References (50)

1. Allen R.H., Stabler S.P., Lindenbaum J. Relevance of vitamins, homocysteine and other metabolites in neuropsychiatric disorders. Eur. J. Pediatr. 157:(Suppl 2):1998;S122-126.
2. Araki A., Sako Y. Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J. Chromatogr. 422:1987;43-52.
3. Bretsky P.M., Buckwater J.G., Seeman T.E., Miller C.A., Poirier J., Schellenberg G.D., Finch C.E., Henderson V.W. Evidence for an interaction between apolipoprotein E genotype, gender and Alzheimer's disease. Alz. Dis. Assoc. Disord. 13:1999;216-221.
4. Brunelli T., Bagnoli S., Giusti B., Nacmias B., Pepe G., Sorbi S., Abbate R. The C677T methylenetetrahydrofolate reductase mutation is not associated with Alzheimer's disease. Neurosci. Lett. 315:2001;103-105.
5. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel S.E., Gaskel P.C., Small G.W., Roses A.D., Haines J.L., Pericak V.M.A. Gene dose of apolipoprotein E type 4 allele and the rish of Alzheimer's disease in late-onset families. Science. 261:1993;921-923.
6. Cruz-Sanches F.F., Durany N., Thome J., Rieder P., Zambon D. Correlation between apolipoprotein E polymorphism and Alzheimer's disease pathology. J. Alz. Dis. 2:2000;223-229.
7. Growdon J. Incorporating biomarkers into clinical drug trials in Alzheimer's disease. J. Alz. Dis. 3:2001;287-292.
8. Hayek T., Oiknine J., Brook J.G., Aviram M. Increased plasma and lipoprotein lipid peroxidation in apo E-deficient mice. Biochem. Biophys. Res. Commun. 201:1994;1567-1574.
9. Ho P., Ashline D., Dhivat S., Ortiz D., Rogers E., Shea T.B. Homocysteine potentiates Amyloid beta neurotoxicity: Role of oxidative stress. J. Neurochem. 78:2001;249-253.
10. Ibrahim W., Lee U.-S., Yeh C.-C., Szabo J., Bruckner G., Chow C.K. Oxidative stress and antioxidant status in mouse liver: Effects of dietary lipid, vitamin E and iron. J. Nutr. 127:1997;1401-1406.
11. Ignatius M.J., Gebicke-Haeter P.J., Skene J.H.P., Schilling J.W., Weisgraber K.H., Mahley R., Shooter E.M. Expression of apolipoprotein E during nerve degeneration and regeneration. Proc. Natl. Acad. Sci. USA. 83:1986;1125-1129.
12. Keller J.N., Lauderback C.M., Butterfield D.A., Kindy M.S., Markesbery W.R. Amyloid-beta peptide effects on synaptosomes from Apolipoprotein E-deficient mice. J. Neurochem. 74:2000;1579-1586.
13. Kruman I.I., Bruce-Keller A.J., Bredesen D., Waeg G., Mattson M.P. Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis. J. Neurosci. 17:1997;5089-5100.
14. Kruman I.I., Culmsee C., Chan S., Kruman Y., Guo Z., Penix L., Mattson M.P. Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity. J. Neurosci. 20:2000;6920-6926.
15. Kruman I.I., Kumaravel T.S., Lohani A., Pedersen W.A., Roy G., Cutler R.G., Kruman Y., Haughey N., Lee J., Evans M., Mattson M.P. Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of alzheimer's disease. J. Neurosci. 22:2002;1752-1762.
16. Leonarduzzi G., Arkan M.C., Basaga H., Chiarpotto E., Sevanian A., Poli G. Lipid oxidation products in cell signaling. Free Rad. Biol. Med. 28:2000;1370-1378.
17. Lomnitski L., Chapman S., Hochman A., Kohen R., Shohami E., Chen Y., Trembvler V., Michaelson D.W. Antioxidant mechanisms in apolipoprotein E deficient mice prior to and following closed head injury. Biochim. Biophys. Acta. 1453:1999;359-368.
18. Lovell M.A., Ehmann W.D., Butler S.M., Markesbery W.R. Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer's disease. Neurobiol. Aging. 18:1995;457-461.
19. Masliah E., Mallory M., Ge N., Alford M., Veinbergs I., Roses A.D. Neurodegeneration in the central nervous system of apoE-deficient mice. Exp. Neurol. 136:1995;107-122.
20. Miller J.W. Homocysteine, Alzheimer's disease and cognitive function. Nutrition. 16:2000;675-677.
21. Miranda S., Opazo C., Larrondo L.F., Munoz F.J., Ruiz F., Leighton F., Inestrosa H.C. The role of oxidative stress in the toxicity induced by amyloid beta peptide in Alzheimer's disease. Prog. Neurobiol. 62:2000;633-648.
22. Miyata M., Smith J.D. Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides. Nat. Gen. 14:1996;55-61.
23. Nourhashemi F., Gillette-Guyonnet S., Andrieu S., Ghisolfi A., Ousset P.J., Grandjean H., Grand A., Pous J., Vellas B., Albarede J.L. Alzheimer disease: protective factors. Am. J. Clin. Nutr. 71:2000;643S-649S.
24. Nunomura A., Perry G., Pappolla M.A., Wade R., Hirai K., Chiba S., Smith M.A. RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease. J. Neurosci. 19:1999;1959-1964.
25. Pedersen W.A., Chan S.L., Mattson M.P. A mechanism for the neuroprotective effect of Apolipoprotein E: Isoform-specific modification by the lipid peroxidation product 4-hydroxynonenal. J. Neurochem. 74:2000;1426-1433.
26. Piedrahita J.A., Zhang S.H., Hagamen J.R., Olver P.M., Maida N. Genetics of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc. Natl. Acad. Sci. USA. 89:1992;4471-4475.
27. Pietrzik K., Bronstrup A. Vitamins B12, B6 and folate as determinants of homocysteine concentration in the healthy population. Eur. J. Pediatr. 157:1998;S135-S138.
28. Pitas R.E., Boyles J.K., Lee S.H., Foss D., Mahley R.W. Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins. Biochim. Biophys. Acta. 917:1987;148-161.
29. Poirier J., Hess M., May P.C., Finch C.E. Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning. Mol. Brain Res. 11:1991;97-106.
30. Reich E.E., Montine K.S., Gross M.D., Roberts II L.J., Swift L.L., Morrow J.D., Montine T.J. Interactions between apolipoprotein E gene and dietary alpha-tocopherol influence cerebral oxidative damage in aged mice. J. Neurosci. 21:2001;5993-5999.
31. Ramassamy C., Averill D., Beffert L., Throux L., Lussier-Cacan S., Cohn J.S., Christen Y., Schoofs J., Davignon J. Oxidative damage and protection by antioxidants in the frontal cortex of Alzheimer's disease is related to the apolipoprotein E genotype. Free Rad. Biol. Med. 27:1999;544-553.
32. Ramassamy C., Averill D., Beffert L., Throux L., Lussier-Cacan S., Cohn J.S., Christen Y., Schoofs J., Davignon J., Poirier J. Oxidative insults are associated with apolipoprotein E genotype in Alzheimer's disease. Neurobiol. Dis. 7:2000;23-37.
33. Ramassamy C., Kryzwkowski P., Averill D., Lussier-Cacan S., Throux L., Christen Y., Davignon J., Poirier J. Impact of apoE deficiency on oxidative insults and antioxidant levels in the brain. Mol. Brain Res. 86:2001;76-83.
34. Regland B., Blennow K., Germgard T., Koch-Schmidt A.-C., Gottfries C.-G. The role of the polymorphic genes apolipoprotein E and methylene-tetrahydrofolate reductase in the development of dementia of the Alzheimer type. Dement. Geriart. Cogn. Disord. 10:1999;245-251.
35. Sano M., Ernesto C., Thomas R.G., Klauber M.R., Schafer K., Grundman M., Woodbury P., Growdin J., Cotman C.W., Pfeiffer E., Schneider L.S., Thal L.J. A controlled trial of slelginine, alpha-tocopherol and both as a treatment for Alzheimer's disease: The Alzheimer's disease cooperative study. New Engl. J. Med. 336:1997;1216-1222.
36. Sayre L.M., Zelasko D.A., Harris P.L., Perry G., Salomon R.G., Smith M.A. 4-hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J. Neurochem. 68:1997;2092-2097.
37. Serot J.M., Christman D., Dubost T., Bene M.C., Faure G.C. CSF-folate levels are decreased in late-onset AD patients. J. Neural. Transm. 108:2001;93-99.
38. Seshadri S., Beiser A., Selhub J., Jacques P., Rosenberg I., D'agostino R., Wilson P.W., Wolf P.A. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. New Engl. J. Med. 346:2002;476-483.
39. T.B. Shea, J. Lyons-Wieler, E. Rogers, Homocysteine, folate deprivation and Alzheimer's disease, J. Alz. Dis., 2002, in press.
40. Smith M.A., Rottkamp C.A., Nunomura A., Raina A.K., Perry G. Oxidative stress in Alzheimer's disease. Biochim. Biophys. Acta. 1502:2000;139-144.
41. Snipes G.J., McGuire C.B., Norden J.J., Freman J.A. Proc. Natl. Acad. Sci. USA. 83:1986;1130-1134.
42. Snowdon D.A., Tully C.L., Smith C.D., Riley D., Markesbery W. Serum folate and the severity of atrophy of the neocortex in Alzheimer disease: findings from the Nun Study. Am. J. Clin. Nutr. 71:2000;993-998.
43. Subramaniam R., Koppal T., Green M., Yatin S., Jordan B., Drake J., Butterfield D.A. The free radical antioxidant vitamin E protects cortical synaptosomal membranes from amyloid beta-peptide (25-35) toxicity but not from hydroxynonenol toxicity: Relevance to the free radical hypothesis of Alzheimer's disease. Neurochem. Res. 23:1998;1403-1410.
44. Tapiero H., Tew K.D., Gate L., Machover D. Prevention of pathologies associated with oxidative stress and dietary intake deficiencies: folate deficiency and requirements. Biomed. Pharm. 55:2001;381-390.
45. Wang H.X., Wahlin A., Basun H., Fastom J., Winblad B., Fratiglioni L. Vitamin B12 and folate in relation to the development of Alzheimer's disease. Neurology. 56:2001;1188-1194.
46. Whittaker P., Wamer W.G., Chanderbhan R.F., Dunkel V.C. Effects of alpha-tocopherol and beta-carotene on hepatic lipid peroxidation and blood lipids in rats with dietary iron overload. Nutr. Cancer. 25:1996;119-128.
47. Veinbergs I., Mallory M., Sagara Y., Masliah E. Vitamin E supplementation prevents spatial learning deficits and dendritic alterations in aged apolipoprotein E-deficient mice. Eur. J. Neurosci. 12:2000;4541-4546.
48. White A.R., Huang X., Jobling M.F., Barrow C.H., Beyreuther K., Masters C.L., Bush A.I., Cappai R. Homocysteine potentiates copper- and amyloid beta peptide-mediated toxicity in primary cultures: possible risk factors in the Alzheimer's-type neurodegenerative pathways. J. Neurochem. 76:2001;1509-1520.
49. Yan S.D., Chen X., Schmidt A.M., Brett J., Godman G., Zou Y.S., Scott C.W., Caputo C., Frappier T., Smith M.A., Perry G., Yen S.H., Stern D. Glycated tau protein in Alzheimer's disease: A mechanism for induction of oxidant stress. Proc. Natl. Acad. Sci. USA. 91:1994;7787-7791.
50. Zittoun J. Congenital errors of folate metabolism. Baillieres Clin. Haematol. 8:1995;603-616.